AIRLINK 72.10 Decreased By ▼ -0.08 (-0.11%)
BOP 5.01 Increased By ▲ 0.08 (1.62%)
CNERGY 4.38 Increased By ▲ 0.03 (0.69%)
DFML 30.52 Increased By ▲ 2.03 (7.13%)
DGKC 82.95 Increased By ▲ 1.65 (2.03%)
FCCL 21.85 Increased By ▲ 0.35 (1.63%)
FFBL 32.70 Decreased By ▼ -0.35 (-1.06%)
FFL 9.90 Increased By ▲ 0.04 (0.41%)
GGL 10.54 Increased By ▲ 0.06 (0.57%)
HBL 113.00 Decreased By ▼ -1.00 (-0.88%)
HUBC 136.80 Decreased By ▼ -3.20 (-2.29%)
HUMNL 10.03 Increased By ▲ 1.00 (11.07%)
KEL 4.75 Increased By ▲ 0.02 (0.42%)
KOSM 4.45 Increased By ▲ 0.07 (1.6%)
MLCF 37.82 Increased By ▲ 0.17 (0.45%)
OGDC 133.60 Decreased By ▼ -0.10 (-0.07%)
PAEL 26.78 Increased By ▲ 1.18 (4.61%)
PIAA 24.35 Increased By ▲ 0.37 (1.54%)
PIBTL 6.49 Increased By ▲ 0.01 (0.15%)
PPL 121.65 Decreased By ▼ -0.97 (-0.79%)
PRL 27.10 Increased By ▲ 0.03 (0.11%)
PTC 13.90 Increased By ▲ 0.30 (2.21%)
SEARL 59.35 Increased By ▲ 2.73 (4.82%)
SNGP 68.30 Decreased By ▼ -0.94 (-1.36%)
SSGC 10.28 Decreased By ▼ -0.06 (-0.58%)
TELE 8.68 Increased By ▲ 0.23 (2.72%)
TPLP 11.18 Decreased By ▼ -0.10 (-0.89%)
TRG 61.55 Increased By ▲ 0.34 (0.56%)
UNITY 25.24 Decreased By ▼ -0.09 (-0.36%)
WTL 1.55 Increased By ▲ 0.05 (3.33%)
BR100 7,597 Decreased By -33 (-0.43%)
BR30 24,967 Decreased By -22.7 (-0.09%)
KSE100 72,560 Decreased By -41.8 (-0.06%)
KSE30 23,376 Decreased By -162.1 (-0.69%)

The US is fast-tracking the anti-malarial drug chloroquine for use as a treatment against the new coronavirus, President Donald Trump said Thursday.
"We're going to be able to make that drug available almost immediately, and that's where the FDA (Food and Drug Administration) has been so great," Trump told reporters. "They've gone through the approval process - it's been approved. They took it down from many, many months to immediate. So we're going to be able to make that drug available by prescription."
But the FDA Commissioner Stephen Hahn later indicated that, while the drug has not yet been formally approved, access to it was being expanded so that authorities could gather more data.
This is known as "compassionate use."
"If there is an experimental drug that is potentially available, a doctor could ask for that drug to be used in a patient. We have criteria for that and very speedy approval for that," said Hahn.

Copyright Agence France-Presse, 2020

Comments

Comments are closed.